|
Drug Therapy
Citations 211-220 of 297 total displayed.
|
Past content
(since Feb 1998):
|
- Controversies
Using a Drug Before the Risks and Benefits Are Known From a Phase 3 Clinical Trial: Thoughts on Compassion
- Joan W. Miller
Arch Ophthalmol 2006; 124: 1029-1031.
[Extract]
[Full text]
[PDF]
- Controversies
Uncertain Compassion in Using a Drug Before the Risks and Benefits Are Known
- Raja Narayanan; Baruch D. Kuppermann
Arch Ophthalmol 2006; 124: 1032-1034.
[Extract]
[Full text]
[PDF]
- Clinicopathologic Reports, Case Reports, and Small Case Series
A Case of Tamoxifen Keratopathy
- Olga Zinchuk; Makio Watanabe; Nobutsugu Hayashi; Atsuki Fukushima; Hisayuki Ueno
Arch Ophthalmol 2006; 124: 1046-1048.
[Extract]
[Full text]
[PDF]
- Clinicopathologic Reports, Case Reports, and Small Case Series
Infliximab-Associated Third Nerve Palsy
- Fahhad I. Farukhi; Kathryn Bollinger; Paul Ruggieri; Michael S. Lee
Arch Ophthalmol 2006; 124: 1055-1057.
[Extract]
[Full text]
[PDF]
- Clinicopathologic Reports, Case Reports, and Small Case Series
Tadalafil-Induced Subretinal and Choroidal Hemorrhage in a Patient With an Unsuspected Uveal (Choroidal and Ciliary Body) Melanoma
- David H. Abramson; Indira S. Rollins; Amy Lin; Peter Odell; Robert Folberg
Arch Ophthalmol 2006; 124: 1058-1060.
[Extract]
[Full text]
[PDF]
- Correspondence
Use of Higher Medication Concentrations in the Treatment of Acanthamoeba Keratitis
- William Mathers
Arch Ophthalmol 2006; 124: 923.
[Extract]
[Full text]
[PDF]
- Editorials
Nonarteritic Anterior Ischemic Optic Neuropathy and Sildenafil
- Frederick W. Fraunfelder; Howard D. Pomeranz; Robert A. Egan
Arch Ophthalmol 2006; 124: 733-734.
[Extract]
[Full text]
[PDF]
- Clinicopathologic Reports, Case Reports, and Small Case Series
Ocular Adverse Effects Associated With Cyclooxygenase-2 Inhibitors
- Frederick W. Fraunfelder; Jonathan Solomon; Thomas J. Mehelas
Arch Ophthalmol 2006; 124: 277-279.
[Extract]
[Full text]
[PDF]
- Correspondence
Convergence Insufficiency: Randomized Clinical Trial—Reply
- Mitchell Scheiman; G. Lynn Mitchell; Susan Cotter; Jeffrey Cooper; Marjean Kulp; Michael Rouse; Eric Borsting; Richard London; Janice Wensveen; the Convergence Insufficiency Treatment Trial (CITT) Study Group
Arch Ophthalmol 2005; 123: 1760-a-1761-a.
[Extract]
[Full text]
[PDF]
- Correspondence
Convergence Insufficiency: Randomized Clinical Trial
- Jitendra Jethani
Arch Ophthalmol 2005; 123: 1760.
[Extract]
[Full text]
[PDF]
|
|
